Ask AI
ProCE Banner Activity

Use of MRD in Multiple Myeloma

Slideset

Download this slideset featuring expert perspectives on the potential of MRD negativity as surrogate marker for PFS and early endpoint to support drug approval in multiple myeloma.

Released: May 30, 2025

Expiration: November 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb